Not Alzheimer's?
Our services are also for these related disorders.

Alzheimer's Association, New York City Chapter

  • 24-hour helpline: 800.272.3900
  • Translation available in 140 languages
  • Click here to contact us

 

Search
 
Select a Topic
 
Newsletter Home
For Those We Love:
Jazz Benefit
Reflections
Louise Rogers and
Peter Eldridge
2007 Early Stage Memory Disorders Forum
President's Message
From the
Program Director
From the Editor's Desk
Alzheimer’s Association Safe Return®
Dementia Home Care Training Graduations
Partnering with
Your Doctor
Part VI:
During The Doctor's Visit
Ask Reva
If It’s Not Alzheimer’s...
Dementia with
Lewy Bodies
Alzheimer’s In the News
African American Outreach Update
Point/Counter Point:
Disease-modifying Treatments
Caregivers’ Corner
Oral Health for Persons with AD
Caregiver Profile
Please See Us
Safely Home
Reflections
Dr. Richard Mayeux
Public Policy Update
Fight For A Cure Now
Legal Guidance
Civil Monetary Penalties Partnership Summit
Volunteer Corner
Junior Committee Update
Women in Action
Ways to Give
Naming Opportunities
Development Report
Tributes
N.Y.C.A.R.E.
OMEGA-3 Fatty Acids
and AD
Clinical Trials
ALZNYC Online Store
HonorGift Tribute Cards
Memory Walk 2007
Bulletin Board
Chapter Staff
Board of Directors
Education Calendar
Support Groups
 

En Español
Archived Versions
Featured Articles Index
 
 
   
   
 
2007 Early Stage Memory Disorders Forum
 
Text Size A  A  A

Reflections on Living with Early Stage Memory Loss

There’s a new face of Alzheimer’s, and judging by the number of those with early stage Alzheimer’s who participated in this year’s forum, there is an increasing population holding steady in the early stage for six, seven, eight or more years. Medications help them to thrive, along with social networks and support groups tailored to their concerns.

The sellout crowd at The Roosevelt Hotel on April 11 may be attributable to Alzheimer’s higher profile in the media, suggested Chapter President and CEO
Lou-Ellen Barkan in her welcoming remarks. Then Thomas Hendricks, a member of an early stage support group shared his credo, “not to let tomorrow kill today.” Jed Levine, the NYC Chapter’s Director of Programs & Services, introduced David Shenk, author of “The Forgetting,” an important book that became a PBS broadcast.


Keynote Speaker David Shenk

He saluted those early stage people who are aware, able to fight, and take part in decisions affecting them. In the past, he noted, few lived long enough to develop Alzheimer’s, although the malady was mentioned in literature by Homer, Plato, Aristotle, Chaucer and Tolstoy, all before Dr. Alois Alzheimer gave the syndrome a name 100 years ago. Shenk sees the aging of the baby boomers en masse as a major reason to seek increased federal funding for research.

After taking a moment to remember the late Frank Carlino, whose AD spurred him to action and advocacy, Susan Goldfein, Ed.D., Early Stage Forum Coordinator, moderated a discussion among William Deutsch, Margaret Henighan, Anthony Laureano and Natalie Post (early stage support group members) and facilitated by support group leaders Elizabeth Fine and Paulette Michaud.

The group is a safe harbor, as they are non-judgmental and empathy abounds. Members share problems as well as coping strategies. All these member-speakers are on Aricept, Exelon, Razadine and/or Namenda. They don’t go out of their way to share their diagnosis. As Ms.Post commented,“ I cannot bear the thought of losing it; it’s scary.”

The attendees then had a choice of six workshops to address specific concerns. In the one called “Our Toughest Challenges,” we heard from Mary Carver, who was fired when she told the boss she had AD. With early onset AD, lapses are more likely to be picked up at work than by the family. Early Stagers told us that communication must slow down a bit, and they do better scheduling fewer activities.

Loss of initiative is common in early stagers. It’s hard to get them started, so they need extra patience from those they are interacting with. Ask early stagers if they need help—don’t just make all the decisions for them.

After luncheon, everyone reconvened for a discussion of “Participating in Research: What’s in it for me?” Mary Sano, Ph.D., Professor of Psychiatry, Director of the AD Research Center, Mt. Sinai School of Medicine, and Director of Research and Development, Bronx VA Medical Center took the lead in enumerating current treatments, as well as discussing experimental medications which are or will be clinically tested soon. The benefits of participating were laid out: standardized evaluations, access to up-to-date research initiatives and earliest access to new medications. There is also family support in these studies and the altruistic notion of making a contribution to science for the greater good.

Lou Ellen Barkan was on the panel as one who had joined the research as a control subject, and found it “extremely interesting.” Jill and Richard Kushel reflected on their experiences as well. (Info on trials may be found by calling Mt. Sinai at 212-241-8329, Columbia at 212-305-1818, NYU at 212-263-8088 or the NYC Chapter at 800-272-3900.)

At the end of the day, one participant found “a full lack of fear about Alzheimer’s after this conference.” Clearly, support and medication can prolong the time early stagers remain in the early stage.

— Chris MacLeod

Dr. Mary Sano, Jed Levine, Richard & Jill Kushel and Lou-Ellen Barkan
   
Early Stage Forum participants
Early Stage Support Group
   
Click here to view our entire Early Stage Memory Disorders Forum and other Chapter event photographs.

Previous | Next

 
 
 
  Donate | About this Site | Security | Privacy Policy | Disclaimer | Staff Login


igive
up to 26% of your next online purchase can go towards ALZNYC
Wise Giving Alliance Standard
Seal of Approval